SciELO - Scientific Electronic Library Online

 
vol.24 número4Factors associated to mortality at 30 days in patients over 75 years who underwent cardiac catheterizationIncidence of major adverse cardiovascular events associated to suspension of dual antiplatelet therapy in patients with coronary disease and stent implants índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista Colombiana de Cardiología

versão impressa ISSN 0120-5633

Resumo

ALVAREZ-CEBALLOS, Juan Camilo et al. Determining cardiovascular risk in a population group. Rev. Colomb. Cardiol. [online]. 2017, vol.24, n.4, pp.334-341. ISSN 0120-5633.  https://doi.org/10.1016/j.rccar.2016.08.002.

Motivation:

To determine cardiovascular risk with Framingham, Framingham Colombia, Procam, and Procam Colombia in the population of the cardiovascular risk program of a first level institution in the city of Armenia, Quindío.

Methods:

A cross-sectional, descriptive study was conducted that selected as population the participants of the cardiovascular risk program of a first level health institution in the city of Armenia, Quindío, between 1st of January and 31st of December 2015. Average variables, standard deviation and confidence intervals were described with a comparative gender-sensitive analysis of risk factors for each scale.

Results:

The average age in the cardiovascular risk program was 64.54 years, and a body mass index of 27.71 m2/kg. 76.48% presents arterial hypertension, 20.86% diabetes mellitus and 9.36% smoke. Cardiovascular risk according to the Framingham scale is 11.36%, and with Framingham Colombia it is 8.52%. According to Procam scale it is 9.44%, and with Procam Colombia it is 8.81%.

Body mass index, age and LDL cholesterol are not statistically significant for risk assessment with Framingham and Framingham Colombia scales.

Conclusion:

The proposed appropriate scale for measuring cardiovascular risk in this population group is the Procam or Procam Colombia scale, because it identifies almost all variables in a significant way. Framingham and Framingham Colombia scales must be used with caution for this population group

Palavras-chave : Cardiovascular disease; Cardiovascular risk factors; Validation studies.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )